Choose a channel
Check out the different Progress in Mind content channels.
Progress in Mind
Clinicians value biomarkers when assessing mild cognitive impairment (MCI) but are less certain about how best to discuss their implications with patients.
Tau-PET imaging in the clinic is on the horizon and would complement amyloid-PET and structural and functional MRI in our search for tools in the differential diagnosis and staging of demen